Pharma major Biocon is set to announce its Q3FY26 results on 12 Feb 2026. Brokerage reports project a strong Q3FY26 for ...

Pattern Group carries a $15.7 target and 13% upside from 46% Q3 revenue growth, 122% NRR, 6.4% EBITDA margin, and TikTok ...

Heritage Insurance holds a $35 target with a 76.8% combined ratio, 6x forward earnings, and potential 2025 EPS beats. Find ...

Parle Products reports an 8.5% revenue growth to Rs 15,568.49 crore in FY25, while Britannia retains its leadership in the ...

India's upcoming Union Budget 2026-27 presents a chance to boost economic growth. The focus is on refining the Goods and ...

Strong protection momentum, margin discipline and deeper tier-III expansion underpin the insurer’s medium-term growth outlook ...

On January 16, 2026, Secretary of War Pete Hegseth announced that the Department of War will be conducting a comprehensive ...

Parle Products saw revenue rise in FY25 but profitability declined amid fierce competition. Britannia Industries remained the ...

Bill Nye has spent the past year warning that deep cuts to NASA would be an "extinction-level event" for American space ...

Parle's revenue rises 8.5% to ₹15,568.49 crore in FY25, while Britannia retains its biscuit market leadership.

Wrongly retired at 58, employee fought against employer and wins case: High Court restores his job and two lost years of pay ...

Detailed price information for Ironwood Pharmaceuti (IRWD-Q) from The Globe and Mail including charting and trades.